Myasthenia gravis and Atelectasis

Summary:

Atelectasis is found among people with Myasthenia gravis, especially for people who are female, 60+ old.

The study analyzes which people have Atelectasis with Myasthenia gravis. It is created by eHealthMe based on reports of 20 people who have Myasthenia gravis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Myasthenia gravis?

Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily) is found to be associated with 544 drugs and 716 conditions by eHealthMe. Check the latest studies of Myasthenia gravis.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,434 drugs and 1,639 conditions by eHealthMe. Check the latest studies of Atelectasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

20 people who have Myasthenia Gravis and Atelectasis are studied.

Would you have Atelectasis when you have Myasthenia gravis?

Gender of people who have Myasthenia Gravis and experienced Atelectasis *:

female: 72.22 %
male: 27.78 %

Age of people who have Myasthenia Gravis and experienced Atelectasis *:

Common co-existing conditions for these people *:

Oxygen Saturation Decreased: 2 people, 10.00%
General Anaesthesia: 2 people, 10.00%
Stress And Anxiety: 1 person, 5.00%
Skin Striae (irregular areas of skin that look like bands, stripes, or lines): 1 person, 5.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.00%
Psychiatric Symptom: 1 person, 5.00%
Ocular Myasthenia (a disease of the neuromuscular junction resulting in hallmark variability in muscle weakness and fatigability): 1 person, 5.00%
Insomnia (sleeplessness): 1 person, 5.00%
Headache (pain in head): 1 person, 5.00%

Common drugs taken by these people *:

Soliris: 8 people, 40.00%
Prednisone: 6 people, 30.00%
Mestinon: 5 people, 25.00%
Pyridostigmine Bromide: 3 people, 15.00%
Potassium Chloride: 3 people, 15.00%
Acetaminophen: 2 people, 10.00%
Dulera: 2 people, 10.00%
Epinephrine: 2 people, 10.00%
Promethazine Hydrochloride: 2 people, 10.00%
Prograf: 2 people, 10.00%

Common symptoms for these people *:

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 35.00%
Dyspnea (difficult or laboured breathing): 7 people, 35.00%
Fatigue (feeling of tiredness): 5 people, 25.00%
Pneumonia: 4 people, 20.00%
Diabetes: 4 people, 20.00%
Pleural Effusion (water on the lungs): 4 people, 20.00%
Stress And Anxiety: 3 people, 15.00%
Chills (felling of cold): 3 people, 15.00%
Cough: 3 people, 15.00%
Respiratory Tract Infection: 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Myasthenia gravis (22,230 reports)
Atelectasis (17,087 reports)

All the drugs that are associated with Atelectasis:

Atelectasis (1,434 drugs)

All the conditions that are associated with Atelectasis:

Atelectasis (1,639 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atelectasis and Myasthenia gravis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.